{
    "clinical_study": {
        "@rank": "142751", 
        "brief_summary": {
            "textblock": "In this study the consequences of exacerbations will be visualized by high resolution\n      computed tomography (HRCT) scan at functional residual capacity (FRC) and total lung\n      capacity (TLC) as taken during an episode of exacerbation and after recovering. Changes in\n      HRCT based airway dimensions and computational fluid dynamic (CFD) -based resistance values\n      will be correlated with changes in patient reported outcomes (PROs) and lung function tests\n      recorded at the same time."
        }, 
        "brief_title": "Research to Evaluate a Possible Relation Between Values Obtained After Processing CT Images, Lung Function Tests and the Experience of the Patient During an Exacerbation in COPD Patients.", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Pulmonary Disease, Chronic Obstructive", 
        "condition_browse": {
            "mesh_term": [
                "Chronic Disease", 
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female, \u2265 40 years old\n\n          -  COPD as defined by the global Initiative on obstructive lung disease4\n\n          -  Post-bronchodilator FEV1/FVC < 70% AND post-bronchodilator FEV1 <80%pred as\n             documented in the last 5 years.\n\n          -  Smoking history of at least 10 pack-years\n\n          -  At entry in the study experiencing an exacerbation defined as an acute change in the\n             patient 's baseline dyspnea, cough, and/or sputum that is beyond normal day to day\n             variations, and that necessitates the administration or doubling of systemic\n             corticosteroid treatment.\n\n          -  Patients must be able to understand and complete protocol requirements, instructions,\n             questionnaires and protocol-stated restrictions.\n\n          -  Written and signed informed consent\n\n        Exclusion Criteria:\n\n          -  Pregnant or lactating females\n\n          -  Patient diagnosed with asthma\n\n          -  Patient with pneumonia as defined radiologically at the start of the exacerbation\n\n          -  Patient with a history of or presence of lung cancer\n\n          -  Patient with an indication for non-invasive ventilation\n\n          -  Patient unlikely to comply with the protocol or unable to understand the nature,\n             scope and possible consequences of the study.\n\n          -  Patient who received any investigational new drug within the last 4 weeks prior to\n             visit 1."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01684384", 
            "org_study_id": "FLUI-2011-79"
        }, 
        "intervention": {
            "description": "HRCT scan at FRC and TLC as taken during an episode of exacerbation and after recovering.", 
            "intervention_name": "Functional Respiratory Imaging", 
            "intervention_type": "Radiation", 
            "other_name": "HRCT scan"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pulmonary Disease, Chronic Obstructive", 
            "COPD", 
            "Exacerbation", 
            "Functional Respiratory Imaging", 
            "High Resolution Computed Tomography", 
            "HRCT scan", 
            "Patient Reported Outcome", 
            "PRO", 
            "Computational Fluid Dynamic", 
            "CFD", 
            "Lung function parameters"
        ], 
        "lastchanged_date": "September 10, 2012", 
        "location": [
            {
                "contact": {
                    "email": "wilfried.de.backer@uza.be", 
                    "last_name": "Wilfried De Backer, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Edegem", 
                        "country": "Belgium", 
                        "state": "Antwerp", 
                        "zip": "2650"
                    }, 
                    "name": "Antwerp University Hospital"
                }, 
                "investigator": {
                    "last_name": "Wilfried De Backer, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "massimo.pistolesi@unifi.it", 
                    "last_name": "Massimo Pistolesi, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Florence", 
                        "country": "Italy", 
                        "zip": "50134"
                    }, 
                    "name": "University of Florence"
                }, 
                "investigator": {
                    "last_name": "Massimo Pistolesi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "h.a.m.kerstjens@umcg.nl", 
                    "last_name": "Huib AM Kerstjens, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Groningen", 
                        "country": "Netherlands", 
                        "zip": "9700RB"
                    }, 
                    "name": "University Medical Center Groningen"
                }, 
                "investigator": {
                    "last_name": "Huib AM Kerstjens, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "e.wouters@mumc.nl", 
                    "last_name": "Emiel FM Wouters, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Maastricht", 
                        "country": "Netherlands", 
                        "zip": "6229HX"
                    }, 
                    "name": "Maastricht University Medical Center"
                }, 
                "investigator": {
                    "last_name": "Emiel FM Wouters, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Italy", 
                "Netherlands"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "Correlation of Functional Respiratory Imaging Parameters With Lung Function Parameters and Patient Reported Outcome Measures During Exacerbation of COPD.", 
        "other_outcome": {
            "description": "As tertiary objective the reproducibility of the segmentations done by the centers will be evaluated. To accomplish reproducible segmentations the multiple centers will be guided to perform accurate segmentations, and bottlenecks in the usage of the program will be identified and resolved in order to simplify it where necessary and possible.", 
            "measure": "Reproducibility of segmentation", 
            "safety_issue": "No", 
            "time_frame": "Within 1 month of visit"
        }, 
        "overall_official": [
            {
                "affiliation": "University Hospital, Antwerp", 
                "last_name": "Wilfried De Backer, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University Medical Centre Groningen", 
                "last_name": "Huib AM Kerstjens, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Maastricht University Medical Center", 
                "last_name": "Emiel FM Wouters, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Florence", 
                "last_name": "Massimo Pistolesi, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The primary objective of this study is to evaluate whether changes in HRCT based airway dimensions and Computational Fluid Dynamic (CFD)-based resistance values correlate with changes in lung function parameters, under the conditions of exacerbation of COPD as well as after recovering from exacerbation.", 
                "measure": "Changes in functional respiratory imaging parameters", 
                "safety_issue": "No", 
                "time_frame": "Baseline (= during exacerbation) and after about 6 weeks (= after recovering)"
            }, 
            {
                "description": "The primary objective of this study is to evaluate whether changes in HRCT based airway dimensions and Computational Fluid Dynamic (CFD)-based resistance values correlate with changes in lung function parameters, under the conditions of exacerbation of COPD as well as after recovering from exacerbation.", 
                "measure": "Changes in lung function parameters", 
                "safety_issue": "No", 
                "time_frame": "Baseline (= during exacerbation) and after about 6 weeks (= after recovering)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01684384"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The secondary objective is to check if the changes in CFD data actually correlate better with changes in PRO than changes in lung function parameters.", 
            "measure": "Changes in patient reported outcome (PRO) measures", 
            "safety_issue": "No", 
            "time_frame": "Baseline (= during exacerbation) and after about 6 weeks (= after recovering)"
        }, 
        "source": "FluidDA nv", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "FluidDA nv", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}